12.40
前日終値:
$11.81
開ける:
$12.25
24時間の取引高:
1.24M
Relative Volume:
0.89
時価総額:
$944.62M
収益:
$11.40B
当期純損益:
$-95.73M
株価収益率:
-5.0612
EPS:
-2.45
ネットキャッシュフロー:
$-64.37M
1週間 パフォーマンス:
+1.64%
1か月 パフォーマンス:
+31.57%
6か月 パフォーマンス:
+128.73%
1年 パフォーマンス:
+129.58%
Mind Medicine Inc Stock (MNMD) Company Profile
MNMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MNMD
Mind Medicine Inc
|
12.41 | 898.60M | 11.40B | -95.73M | -64.37M | -2.45 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.43 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.80 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.59 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
801.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
330.89 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-04 | 再開されました | Oppenheimer | Outperform |
2025-01-28 | 開始されました | Evercore ISI | Outperform |
2024-12-20 | 開始されました | Chardan Capital Markets | Buy |
2024-10-14 | 再開されました | Leerink Partners | Outperform |
2024-07-24 | 開始されました | ROTH MKM | Buy |
2024-05-29 | 開始されました | Robert W. Baird | Outperform |
2024-04-15 | 開始されました | Leerink Partners | Outperform |
2023-12-05 | 開始されました | Canaccord Genuity | Buy |
2022-12-09 | 再開されました | ROTH Capital | Buy |
2022-11-16 | 開始されました | RBC Capital Mkts | Outperform |
2022-08-26 | 開始されました | Oppenheimer | Outperform |
2022-08-10 | 開始されました | Cantor Fitzgerald | Overweight |
2022-05-04 | 開始されました | ROTH Capital | Buy |
2021-06-28 | 開始されました | Maxim Group | Buy |
すべてを表示
Mind Medicine Inc (MNMD) 最新ニュース
Needham Initiates Mind Medicine (MindMed) at Buy With $28 Price Target - MarketScreener
Mind Medicine (MNMD) Gains "Buy" Rating with New Coverage Initia - GuruFocus
Price action breakdown for Mind Medicine (MindMed) Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - newser.com
Why Mind Medicine Stock Is Skyrocketing Today - AOL.com
Is this a good reentry point in Mind Medicine (MindMed) Inc.Watch List & Trade Opportunity Analysis Reports - newser.com
Can a trend reversal in Mind Medicine (MindMed) Inc. lead to recoveryJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
Is Mind Medicine (MindMed) Inc. stock ready for a breakoutJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
What MACD and RSI say about Mind Medicine (MindMed) Inc.July 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Is Mind Medicine (MindMed) Inc. meeting your algorithmic filter criteriaJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
Relative strength of Mind Medicine (MindMed) Inc. in sector analysisMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com
Using Bollinger Bands to evaluate Mind Medicine (MindMed) Inc.Breakout Watch & Safe Swing Trade Setups - newser.com
What drives Mind Medicine MindMed Inc stock priceTake Profit Strategies & Affordable Investment Tips - earlytimes.in
Mind Medicine (MindMed) (NASDAQ:MNMD) Reaches New 12-Month HighWhat's Next? - MarketBeat
Volatility clustering patterns for Mind Medicine (MindMed) Inc.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Is a relief rally coming for Mind Medicine (MindMed) Inc. holdersInflation Watch & Verified Stock Trade Ideas - newser.com
Will Mind Medicine (MindMed) Inc. (MMQ) stock deliver compounding returnsBear Alert & Verified Trade Idea Suggestions - newser.com
Is Mind Medicine (MindMed) Inc. (MMQ) stock trading at attractive multiplesJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 6.8%Should You Sell? - MarketBeat
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) high institutional ownership speaks for itself as stock continues to impress, up 26% over last week - Yahoo Finance
Mind Medicine (MindMed) (NASDAQ:MNMD) Hits New 12-Month HighShould You Buy? - MarketBeat
Published on: 2025-09-29 08:42:36 - earlytimes.in
MindMed projects 2026 trial readouts for pivotal MM120 studies in GAD and MDD - MSN
MEGMILK SNOW BRAND CoLtd 6MG Stock Analysis and ForecastEarnings Forecast Updates & Individual Stock Tracking Service - Early Times
Is Mind Medicine MindMed Inc a good long term investmentPrice Momentum Alerts & Free Trading Signals to Sharpen Your Edge - earlytimes.in
Is Mind Medicine (MindMed) Inc. showing signs of accumulation2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
Mind Medicine MindMed Inc Stock Analysis and ForecastMonthly Performance Summary & Easy Tools to Analyze Your Investment Risk - earlytimes.in
MindMed (MNMD) Stock: Top Executives Sell Over $362K in Shares as Stock Nears 52-Week High - CoinCentral
Mindmed: chief legal officer Sullivan sells $110k in shares By Investing.com - Investing.com Nigeria
MindMed (MNMD) CEO Barrow sells $252,036 in shares By Investing.com - Investing.com Australia
MindMed (MNMD) CMO Karlin sells $75k in shares By Investing.com - Investing.com Nigeria
MindMed (MNMD) CEO Barrow sells $252,036 in shares - Investing.com India
Mindmed: chief legal officer Sullivan sells $110k in shares - Investing.com India
Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Sells $75,268.08 in Stock - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) CEO Sells $252,036.69 in Stock - MarketBeat
MindMed (MNMD) CMO Karlin sells $75k in shares - Investing.com India
Mind Medicine Inc (MNMD) 財務データ
収益
当期純利益
現金流量
EPS
Mind Medicine Inc (MNMD) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Barrow Robert | Chief Executive Officer |
Sep 25 '25 |
Sale |
9.77 |
25,797 |
252,037 |
804,268 |
Karlin Daniel | Chief Medical Officer |
Sep 25 '25 |
Sale |
9.77 |
7,704 |
75,268 |
430,625 |
大文字化:
|
ボリューム (24 時間):